Just Two Companies On The First UK Novel Food Validated List Published Today

Those from synthetic Pureis CBD and a second company 4MP Technologies have been Validated by the FSA.

Lady Chanelle McCoy of Pureis CBD told BuisnessCann today: “We are very proud and delighted to be one of the first to achieve this milestone after six years of hard work.”

Many companies will be anxious at today’s news, while the FSA has caveated the announcement previously by saying the list will be updated weekly, as more companies pass its Validation process.

Updated Every Week

In a press release to go with the release of the first Public List The FSA said: “The FSA has issued a provisional list of CBD products on sale in England and Wales that can remain on the market because an application for safety assessment has been submitted to the FSA.

‘These applications are making initial progress through the novel foods authorisation process and can therefore remain on sale until a decision on their authorisation has been made.

‘This list of CBD products is subject to change and will be updated on a weekly basis with further products as the FSA processes applications.

‘The final full list is expected to be complete in June 2021. Products that do not appear on the list should be withdrawn from the market.’

Siân Philips Managing Director of the Cannabis Trades Association said: “We look forward to seeing the further list coming out from the FSA as we all suspected the first products to be approved would be from synthetically-produced CBD.”

Compliant CBD Industry

CBD products on this list were on sale on 13 February 2020 and are linked to applications submitted to the FSA before 31 March 2021. The list will be split into two sections that are made up of products associated with applications which either have been validated are ‘on hold’, with applicants having set out robust plans to complete the risk assessment but yet to supply all the information needed to continue on in the process

Emily Miles, Chief Executive of the Food Standards Agency, said: ‘This is about bringing the CBD industry into compliance with the law. Consumers need to be able to trust that these products are safe and are what they say they are. Companies were given until the end of March  to submit their applications for safety assessment. Those who haven’t done this should take their products off the market.

‘Products on the list that have been linked to a validated or on hold application will now undergo a full safety assessment so that a final decision can be made.

‘When complete, the list can be used by suppliers and retailers to confirm the status of particular products and to help local authorities inform their enforcement decisions.

‘The FSA is not endorsing the sale of any of these products, regardless of whether they are on the list or not and inclusion on the list is no guarantee of eventual authorisation; that will be determined on the strength of evidence of safety submitted by the companies.’